Analystreport

Cellectar Biosciences Inc (NASDAQ: CLRB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Cellectar Biosciences, Inc.  (CLRB) 
Last cellectar biosciences, inc. earnings: 11/12 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.cellectar.com